The former research also indicated that PVT1 could promote the chemoresistant ability to gemcitabine and cisplatin by regulating Wnt, autophagy, or PI3K/AKT signaling pathway in osteosarcoma or pancreatic cancer [22, 24, 42]. The gene discussed is AKT1; the disease is familial pancreatic carcinoma.